Trademark applications and grants for Entrada Therapeutics Inc. Entrada Therapeutics Inc has 12 trademark applications. The latest application filed is for "EEV"
Patent Application | Date |
---|---|
CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF 20220177523 - 17/530664 PEI; Dehua ;   et al. | 2022-06-09 |
COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY 20220033787 - 17/495238 SETHURAMAN; Natarajan ;   et al. | 2022-02-03 |
CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF 20200385427 - 16/852615 PEI; Dehua ;   et al. | 2020-12-10 |
COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY 20200354697 - 16/821018 SETHURAMAN; Natarajan ;   et al. | 2020-11-12 |
SEC | 0001689375 | Entrada Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.